Share Us: Subscribe | Contact

Biblio

Export 380 results:

Tagged

Filters: First Letter Of Last Name is E [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

S

M. A. Beydoun, Canas, J. - A., Dore, G. A., Beydoun, H. A., Rostant, O. S., Fanelli-Kuczmarski, M. T., Evans, M. K., and Zonderman, A. B., “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.

S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., “Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.”, J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.

O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.

O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.

B. - E. Kirsebom, Espenes, R., Waterloo, K., Hessen, E., Johnsen, S. Harald, Bråthen, G., Aarsland, D., and Fladby, T., “Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1621-1631, 2017.

R

M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., “The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.

P. Edison and Brooks, D. J., “Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET.”, J Alzheimers Dis, vol. 64, no. s1, pp. S339-S351, 2018.

A. Elias, Cummins, T., Tyrrell, R., Lamb, F., Doré, V., Williams, R., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., and Rowe, C. C., “Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.”, J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.

H. Ulugut Erkoyun, van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., and Pijnenburg, Y., “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.

E. Niemantsverdriet, Ribbens, A., Bastin, C., Benoit, F., Bergmans, B., Bier, J. - C., Bladt, R., Claes, L., De Deyn, P. Paul, Deryck, O., Hanseeuw, B., Ivanoiu, A., Lemper, J. - C., Mormont, E., Picard, G., Salmon, E., Segers, K., Sieben, A., Smeets, D., Struyfs, H., Thiery, E., Tournoy, J., Triau, E., Vanbinst, A. - M., Versijpt, J., Bjerke, M., and Engelborghs, S., “A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).”, J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.

A. Bryndis Einarsdottir, Hardarson, S. Hakon, Kristjansdottir, J. Valgerdur, Bragason, D. Thor, Snaedal, J., and Stefánsson, E., “Retinal oximetry imaging in Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 79-83, 2016.

F. C. T. van der Heide, Mokhtar, S., Khanna, A., Said, M., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Schram, M. T., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Wesselius, A., Savelberg, H. H. C. M., Schaper, N. C., Webers, C. A. B., and Stehouwer, C. D. A., “Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1471-1483, 2023.

C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.

C. Kaindlstorfer, Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiss, G., and Wenning, G. K., “The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1253-1273, 2018.

S. Hani Mouss Nik, Porter, T., Newman, M., Bartlett, B., Khan, I., Sabale, M., Eccles, M., Woodfield, A., Groth, D., Doré, V., Villemagne, V. L., Masters, C. L., Martins, R. N., Laws, S. M., Lardelli, M., and Verdile, G., “Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1479-1489, 2021.

J. Heinrich, Vidal, J. - S., Simon, A., Rigaud, A. - S., Hanon, O., Epelbaum, J., Viollet, C., and Duron, E., “Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1133-1141, 2018.

B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.

M. Elahi, Hasan, Z., Motoi, Y., Matsumoto, S. - E., Ishiguro, K., and Hattori, N., “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.

L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R., “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.

A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.

M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., “Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.”, J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.

M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., “Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.”, J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.

M. S. Rafii, Skotko, B. G., McDonough, M. Ellen, Pulsifer, M., Evans, C., Doran, E., Muranevici, G., Kesslak, P., Abushakra, S., and Lott, I. T., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.

M. S. Rafii, Skotko, B. G., McDonough, M. Ellen, Pulsifer, M., Evans, C., Doran, E., Muranevici, G., Kesslak, P., Abushakra, S., and Lott, I. T., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.

C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.

Pages